Завершено
Фаза III
Беларусь
НЕФЕКОН® · Calliditas Therapeutics AB
An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301